You are here



The Breast Cancer Start-up Challenge: Update

December 20, 2013

05 Feb 2014:

The National Cancer Institute’s Technology Transfer Center, the Avon Foundation and The Center for Advancing Innovation have partnered to create a “first-of-a-kind” Breast Cancer Start-up Challenge. The Challenge is a business plan and start-up challenge among multi-disciplinary university-led teams. The finalists in the best business plan phase of the challenge will launch a start-up, compete for seed funding, and negotiate a license for the invention in the final phase of the challenge.

The primary goal of the Challenge is to stimulate the creation of start-up businesses based upon NCI and Avon Foundation grantee inventions. The Challenge features ten assets that are viewed as having commercial viability with significant public health benefit.

The Challenge is a global effort. 39 teams are participating with team members from universities from Canada, India, the Netherlands, New Zealand, United Kingdom, and the United States. Winners of the Business Plan phase will be announced in late February 2014, and the successful start-ups will be announced Summer 2014.

Although the Challenge is no longer accepting new teams, the public can support the effort by spreading the word and following the Challenge via Facebook (, YouTube (, or Twitter (  For questions, comments, or suggestions, please contact Dr. Rose Freel or Dr. Tom Stackhouse of the NCI TTC (TTC Staff Directory).

NIH Scientists Win 2012 Federal Laboratory Consortium Award for Excellence in Technology Transfer!

August 20, 2012

The Federal Laboratory Consortium (FLC) recently announced that scientists from both the National Cancer Institute (NCI) and the National Institute of Neurological Disorders and Stroke (NINDS) won the prestigious FLC award for Excellence in Technology Transfer. The winners are:

  • Drs. Richard Simon (BRB,NCI) for "An Interactive Software Package for the Analysis of Microarray Data"
  • Drs. Sherry Ansher (CTEP, NCI) and David Newman (DTP, NCI) for "Development of Eribulin, a Potent Anti-Cancer Agent from a Marine Sponge"
  • Dr. Roland Martin (NINDS), Dr. Bibiana Bielekova (NINDS), Dr. Henry McFarland (NINDS), and Dr. Thomas Waldmann (NCI) for "Use of Therapeutic Antibodies as a Novel Treatment for Multiple Sclerosis"
  • Dr. Christy Ludlow (NINDS) for "Vibro-Tactile Stimulation Device and Method for Swallowing Disorders"